Advancements In Personalized Medicine Fueling The Growth Of The Market Due To Increasing Precision In Diagnosis And Treatment Is Supporting Development Across The Celiac Disease Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Expansion Is Expected For The Celiac Disease Market Over The Forecast Period?

The celiac disease market has seen substantial growth recently. It is projected to increase from $0.78 billion in 2025 to $0.87 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.3%. This historical expansion can be attributed to several factors including greater awareness of autoimmune diseases, advancements in diagnostics, the uptake of dietary management strategies, comprehensive hospital gastroenterology care, and robust patient advocacy.

The celiac disease market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $1.27 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 10.0%. This anticipated growth during the forecast period is driven by factors such as the development of new drugs, advancements in gluten-free food products, personalized nutrition approaches, improved early screening initiatives, and ongoing microbiome research. Key developments expected during this period include an increase in the adoption of gluten-free diets, the expansion of packaged gluten-free food options, the proliferation of drug-based treatments, enhanced awareness and diagnosis of the disease, and a greater emphasis on microbiome-focused therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24497&type=smp

What Key Growth Drivers Are Influencing The Celiac Disease Market?

The expansion of personalized medicine is projected to propel the growth of the celiac disease market going forward. This approach to healthcare customizes medical care based on an individual’s genetic profile, environment, and lifestyle. The demand for personalized medicine is increasing due to the growing availability of genetic testing, which facilitates more accurate diagnoses and treatments specifically tailored to individual patient needs. Its advancement supports celiac disease treatment by enabling precise identification of genetic markers and individual immune responses, thereby leading to more targeted and effective management strategies for each patient. For instance, in February 2024, the US-based nonprofit organization, Personalized Medicine Coalition, stated that the FDA authorized 16 personalized therapies in 2023 targeting rare diseases, representing a rise compared to the 6 approved in 2022. Consequently, the growth of personalized medicine will boost the growth of the celiac disease market.

What Key Segment Areas Are Included In The Celiac Disease Market Assessment?

The celiac disease market covered in this report is segmented –

1) By Treatment: Larazotide Acetate, Gluten Free Diet, Other Treatments

2) By Route Of Administration: Oral, Parenteral

3) By End Users: Hospitals, Homecare, Other End-Users

Subsegments:

1) By Larazotide Acetate: Clinical Trial Phase Products, Oral Capsule Formulation, Adult Celiac Patients, Pediatric Investigational Use, Monotherapy And Combination Therapy

2) By Gluten Free Diet: Packaged Gluten-Free Foods, Gluten-Free Bakery Products, Gluten-Free Snacks, Gluten-Free Nutritional Supplements, Gluten-Free Beverages

3) By Other Treatments: Corticosteroids, Immunosuppressive Drugs, Enzyme Therapies, Monoclonal Antibodies, Probiotics And Microbiome Modulators

Which Trends Are Expected To Shape The Celiac Disease Market?

Leading companies in the celiac disease market are concentrating on developing advanced solutions, such as anti-interleukin-15 (IL-15) antibodies, to mitigate tissue damage by curbing hyperactive immune cell activity. Anti-interleukin-15 (IL-15) antibodies are specialized proteins designed to inhibit the function of the IL-15 cytokine, thereby assisting in managing immune system responses and inflammation. For instance, in May 2025, Teva Pharmaceutical Industries, an Israel-based pharmaceutical company, announced that the U.S. Food and Drug Administration had granted Fast Track status for TEV-53408, an investigational anti-interleukin-15 (IL-15) antibody. This is an investigational monoclonal antibody created for individuals with celiac disease who maintain a gluten-free diet. It operates by blocking interleukin-15 (IL-15), a molecule involved in triggering the immune reaction that causes intestinal harm in celiac patients. The therapy is currently being assessed in a Phase 2a clinical trial to determine its safety and effectiveness.

Which Companies Are Influencing The Celiac Disease Market?

Major companies operating in the celiac disease market are Pfizer Inc., Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH, AnTolRx Inc., Nemysis Ltd., Entero Therapeutics Inc.

Access The Complete Celiac Disease Market Report:

https://www.thebusinessresearchcompany.com/report/celiac-disease-global-market-report

Which Region Has The Strongest Presence In The Celiac Disease Market?

North America was the largest region in the celiac disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Celiac Disease Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24497&type=smp

Browse Through More Reports Similar to the Global Celiac Disease Market 2026, By The Business Research Company

Rare Diseases Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Rare Disease Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-disease-diagnostics-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795